Energy Fuels Inc (TSE:EFR) (NYSEMKT:UUUU) hs said it is continuing to build up its inventories of uranium as prices improve, while the group is eyeing cash flow from rare earths within the next 12 months. Reporting second quarter results for the three months to June 30, 2020, the USA's biggest uranium miner, revealed in a statement that at that date it held concentrate worth US$24.7 million. That includes 575,000 pounds of uranium valued at US$23.05 per pound and 1.675 million pounds of vanadium valued at US$5.11 per pound, both as immediately marketable product.
American Battery Metals Corporation (OTCQB:ABML), an advanced extraction and battery recycling technology company with extensive mineral resources in Nevada, announced that inaccurate information was spread about the company and it has no intention to initiate a reverse split of its common stock in the near future. The company would likely need to effectuate a reverse split of its common stock in order to be eligible for its common stock to be listed on a national stock exchange. However, it is not currently taking any substantive steps towards such a listing. American Battery Metals Corporation chief executive officer, Doug Cole, stated, "We continue to make progress in advancing towards commissioning our new battery recycling plant in the first quarter 2021. The company is in negotiation and anticipates financing the building of this initial recycling facility with a conventional 36-month construction financing of approximately $5.5 million including: the purchase cost of the building site, an initial 30,000 square foot industrial building, and initial battery recycling equipment and utility infrastructure. Once the plant is operational, the Company anticipates that this construction financing will be refinanced with long-term project financing with a traditional lending institution."
Co-Diagnostics Inc (NASDAQ:CODX) said that its partner Clinical Reference Laboratory (CRL) has received US Food and Drug Administration (FDA) emergency use authorization for CRL Rapid Response, a saliva-based coronavirus (COVID-19) test that can be self-administered and then tested using Co-Diagnostics' patented CoPrimer technology. According to CRL's announcement, Co-Diagnostics technology drives the “higher sensitivity and specificity” of the self-administered CRL Rapid Response test. CRL is one of the largest privately held clinical testing labs in the US, with dedicated facilities in North America and Europe.
Biocept Inc (NASDAQ:BIOC) announced Monday it has processed to date more than 6,500 COVID-19 specimens using RT-PCR technology at its high-complexity molecular lab. The San Diego-based company also said it has distributed nearly 12,000 COVID-19 PCR specimen collection kits and has about 18,000 additional kits assembled and available for immediate distribution. Biocept said the vast majority of the COVID-19 test results were reported to healthcare providers within 48 hours of receipt of the specimen. The company has received more than 7,000 specimens.
Information Services Corp (TSE:ISV), which provides registry services for public records, revealed that it has completed the previously announced acquisition of all major assets in Paragon Inc’s business for around C$70 million through its wholly-owned subsidiary ESC Corporate Services Ltd. According to the Saskatchewan-based firm, Paragon’s assets now form part of a new division of ESC called Recovery Solutions. Paragon is a tech-enabled company that facilitates asset recovery on behalf of Canada's major banks. Asset recovery often takes the shape of identification, retrieval and disposition of movable assets like cars, boats, aircraft and other physical assets used as collateral in transactions.
Humanigen Inc (OTCQB:HGEN) announced Monday that longtime biotechnology executive and board of directors member Timothy Morris has joined its management team as both chief operating officer and chief financial officer, effective immediately. Morris has worked as an executive at public biotechnology companies for more than two decades, most recently as CFO of Iovance Biotherapeutics Inc (NASDAQ:IOVA), a cancer immunotherapy company. While there, he oversaw the raising of more than $1 billion in equity, and over the course of his career he’s helped companies raise more than $2 billion in total. Morris will be responsible for manufacturing and supply chain, corporate and business development, investor and public relations and human resources, in addition to his CFO duties, the company said. He joins Humanigen as the company is working to advance its drug lenzilumab as a treatment for the coronavirus.
Humanigen also said it will host an investor call and webcast to discuss the National Institute of Health's selection of lenzilumab, the company's proprietary Humaneered anti-human granulocyte macrophage-colony stimulating factor (GM-CSF) monoclonal antibody drug candidate, as an agent to be evaluated in the NIAID-sponsored Big Effect Trial (BET) in hospitalized patients with coronavirus (COVID-19) at 4.30pm EDT on Monday, August 3, 2020. To participate in the conference call, investors can dial toll free (833) 714-0938 or toll number +1 (778) 560-2680. The conference ID number is 1154357. A simultaneous webcast of the call and presentation can be accessed by visiting: https://event.on24.com/wcc/r/2551709/C2EEA514D519C23B4A3E9E777BF19147. In addition, a replay of the webcast will be available on the company website for 30 days following the event.
AEX Gold Inc (CVW:AEX) (LON:AEXG) said the TSX Venture Exchange has accepted for filing documentation with respect to its non-brokered private placement as announced on a news release dated June 30, 2020, which saw the issue of 94,444,445 common shares at a purchase price of 77 cents each with 68 placees.
Hill Street Beverage Company Inc. (CVE:BEER) has announced that further to its press release dated July 21, 2020, the company has received TSX Venture Exchange approval to extend the expiry date of 19,405,804 warrants that were set to expire on July 24, 2020, to December 31, 2020. These warrants were originally issued by the company in connection with one or more concurrent financings relating to a qualifying transaction, which was completed on July 27, 2018. In addition to the forgoing the company also said it intends to apply to the TSX Venture Exchange to amend the exercise price of the above-noted warrants to $0.075, being the closing price of the common shares on July 30, 2020. Approval this amendment is subject to the approval of the TSX Venture Exchange. Finally, the company announces that at its next AGM, it will be seeking shareholder approval to reprice up to 5,892,797 options that were originally issued to insiders of the company in connection with the same public transaction. The options currently have an exercise price of $0.175 per share and the company will be seeking approval to reprice those options to an exercise price of $0.075 per share.
Versus Systems, Inc. (CSE:VS) (OTCQB:VRSSF) (FSE: BMVA) announced that it has granted an aggregate of 2,737,825 incentive stock options to certain directors, officers, employees and consultants under the company's Stock Option Plan, subject to regulatory approval. The options will be exercisable at $0.25 for a period of five years and subject to vesting provisions.
Mineworx Technologies Ltd., (CVE:MWX) (OTCQB:MWXRF) has announced that A.J. Pienaar (Pine) has resigned from the company's board with effect from July 31, 2020. Mineworx president and CEO Greg Pendura commented: “The management and other Directors would like to thank Pine for his services over the last 3 years. Although his contributions will be missed we understand his desire to slow down.”
TRACON Pharmaceuticals (NASDAQ:TCON), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics has announced that its president and CEO, Charles Theuer will present a corporate overview at the 2020 BTIG Virtual Biotechnology Conference on Monday, August 10, at 11:30 am EDT. To access a live webcast of the presentation, please visit the “Events and Presentations” page within the “Investors” section of the TRACON Pharmaceuticals website at www.traconpharma.com.
Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, is to present at the Canaccord Genuity 40th Annual Growth Conference which is being held virtually on August 11 to 13, 2020. Calyxt chief executive officer Jim Blome and its chief financial officer Bill Koschak are scheduled to host a virtual presentation during the conference and will also participate in one-on-one meetings throughout the day. To access the call, which will be on Thursday, August 13, 2020, at 10.00am EST/7.00am PST, investors should dial the toll-free dial-in number: 1-888-221-3881; or use the webcast link: http://wsw.com/webcast/canaccord42/clxt/
Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the Canadian Metals & Mining Virtual lnvestor Conference presentations are now available for on-demand viewing. Investors can log-in or register at: https://bit.ly/2PfQJnn. The company presentations will be available 24/7 for 90 days. Virtual Investor Conferences is part of OTC Market Group Inc's (OTCQX:OTCM) suite of investor relations services specifically designed for more efficient Investor Access. Replicating the look and feel of on-site investor conferences, Virtual Investor Conferences combine leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.
PUDO Inc (CSE:PDO) (OCTQB:PDPTF) CEO Frank Coccia will be presenting at the upcoming OTCQB Venture Company Virtual Investor Conference on August 6 at 10:30 am ET. To watch the presentation please register at www.virtualinvestorconferences.com/login-registration. Viewers can engage in a live Q&A session following the presentation. PUDO is developing North America's only carrier-neutral parcel pick-up/drop-off technology and logistics Network, as a means of solving the last-mile parcel-traffic-control gridlock that challenges the $550B ecommerce sector.
BioSig Technologies Inc (NASDAQ:BSGM), a medical device developer announced that the company has been awarded its Commercial and Government Entity (CAGE) code by the Systems for Award Management. The CAGE code is required to do business operations with the federal government. BioSig, along with its subsidiary ViralClear, are now registered to conduct business with the US government and can be sought out by government agencies for contracts that fit the company. The CAGE code also includes the ability to apply and be awarded government contracts, assistance and grant programs.
Virtual Investor Conferences, the proprietary virtual event series from OTC Markets Group Inc. (OTCQX:OTCM), has released the agenda for its upcoming OTCQB Venture Virtual Investor Conference on Thursday. The free event is designed to connect individual and institutional investors, analysts and advisors with companies on the OTCQB across a variety of industries. The program is scheduled to begin at 9:15 am ET, with the first webcast scheduled for 9:30 am.